738606-46-7
738606-46-7
Chemical Structure
Bempedoic acid
Synonym(s): ETC-1002; ESP-55016
- CAS No.: 738606-46-7
- Formula:C19H36O5
- Molecular Weight:344.49
IUPAC Name: 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
InChIKey: HYHMLYSLQUKXKP-UHFFFAOYSA-N
SMILES: O=C(O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O
Biological Activity: Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor[1]. Bempedoic acid (ETC-1002) activates AMPK[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bempedoic acid | 99.88% | Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor. Bempedoic acid (ETC-1002) activates AMPK. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bempedoic acid (Standard) | ≥98% | Bempedoic acid (Standard) is the analytical standard of Bempedoic acid. This product is intended for research and analytical applications. Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor. Bempedoic acid (ETC-1002) activates AMPK. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bempedoic acid-d4 | 98.0% | Bempedoic acid-d4 is the deuterium labeled Bempedoic acid. Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor. Bempedoic acid (ETC-1002) activates AMPK. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Bempedoic acid-d5 | Bempedoic acid-d5 is the deuterium labeled Bempedoic acid. Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor. Bempedoic acid (ETC-1002) activates AMPK. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Pinkosky SL, et al. AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. J Lipid Res. 2013 Jan;54(1):134-51. [Content Brief]
- [2]. Filippov S, et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. J Lipid Res. 2013 Aug;54(8):2095-108. [Content Brief]
